TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Boule Diagnostics AB
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
48,619
|
51,490
|
49,252 |
| Financial expenses |
1,096
|
1,022
|
890 |
| Earnings before taxes |
-31,407
|
2,713
|
1,874 |
| EBITDA |
-28,312
|
5,933
|
5,048 |
| Total assets |
45,001
|
68,052
|
68,291 |
| Current assets |
22,181
|
25,228
|
30,410 |
| Current liabilities |
22,748
|
18,295
|
17,930 |
| Equity capital |
17,095
|
42,817
|
41,561 |
| - share capital |
845
|
875
|
872 |
| Employees (average) |
226
|
228
|
235 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
38.0%
|
62.9%
|
60.9% |
| Turnover per employee |
215
|
226
|
210 |
| Profit as a percentage of turnover |
-64.6%
|
5.3%
|
3.8% |
| Return on assets (ROA) |
-67.4%
|
5.5%
|
4.0% |
| Current ratio |
97.5%
|
137.9%
|
169.6% |
| Return on equity (ROE) |
-183.7%
|
6.3%
|
4.5% |
| Change turnover |
-1,120
|
2,095
|
7,615 |
| Change turnover % |
-2%
|
4%
|
18% |
| Chg. No. of employees |
-2
|
-7
|
17 |
| Chg. No. of employees % |
-1%
|
-3%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.